Anesth Analg 2000;90:12
© 2000 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
The Effects of Aprotinin on Platelets In Vitro Using Whole Blood Flow Cytometry
Sibylle A. Kozek-Langenecker, MD*,
S. Fazal Mohammad, PhD , ,
Takahisa Masaki, PhD§,
Wayne Green, PhD||,
Craig Kamerath¶, and
Alfred K. Cheung, MD§,¶
*Department of Anesthesiology, University of Vienna, School of Medicine, Vienna, Austria;
Department of Pathology,
Artificial Heart Laboratory,
§Division of Nephrology & Hypertension, Department of Medicine,
||Huntsman Cancer Institute, University of Utah School of Medicine; and
¶Medical and Research Service, Veterans Affairs Medical Center, Salt Lake City, Utah
Address correspondence and reprint requests to Sibylle A. Kozek-Langenecker, MD, Department of Anesthesiology and General Intensive Care, University of Vienna, Währinger Gürtel 18-20, 1090-Vienna, Austria. Address e-mail to sibylle.kozek-langenecker @univie.ac.at.
We sought to evaluate the effects of aprotinin on the number and function of the platelet glycoprotein (GP) IIbIIIa receptor and on the expression of P-selectin in vitro in order to gain insight into the potential mechanisms involved in the platelet-protective action of aprotinin during cardiopulmonary bypass. Aprotinin at 50 to 200 kallikrein inhibiting units/mL decreased the expression of activated GP IIbIIIa complex in response to adenosine diphosphate or thrombin receptor activator peptide 6 in a dose-dependent manner in both citrated and heparinized whole blood experiments. Aprotinin inhibited adenosine diphosphate-induced platelet aggregation, but it exhibited no effect on the expression of GP IIIa and P-selectin. These results indicate that aprotinin interferes with the platelet fibrinogen receptor function during pharmacological activation. Reduced aggregability and platelet adhesion to fibrinogen adsorbed to synthetic surfaces in the presence of aprotinin may prevent platelet consumption during clinical cardiopulmonary bypass. This in vitro study demonstrates that aprotinin decreases the agonist-induced expression of activated GP IIbIIIa receptors that play a major role in platelet aggregation and adhesion to biomaterial surfaces.
Implications: This in vitro study demonstrates that aprotinin decreases the agonist-induced expression of activated glycoprotein IIbIIIa receptors that play a major role in platelet aggregation and adhesion to biomaterial surfaces.
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Mengistu, K. D. Rohm, J. Boldt, J. Mayer, S. W. Suttner, and S. N. Piper
The Influence of Aprotinin and Tranexamic Acid on Platelet Function and Postoperative Blood Loss in Cardiac Surgery
Anesth. Analg.,
August 1, 2008;
107(2):
391 - 397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Swenson, N. Bay, E. Loose, B. Bankhead, J. Davis, T. C. Beals, N. A. Bryan, R. T. Burks, and P. E. Greis
Outpatient Management of Continuous Peripheral Nerve Catheters Placed Using Ultrasound Guidance: An Experience in 620 Patients
Anesth. Analg.,
December 1, 2006;
103(6):
1436 - 1443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. LeGuyader, R. Watanabe, J. Berbe, A. Boumediene, M. Cogne, and M. Laskar
Platelet activation after aortic prosthetic valve surgery
Interactive CardioVascular and Thoracic Surgery,
February 1, 2006;
5(1):
60 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Bedirhan, A. Turna, N. Yagan, and O. Tasci
Aprotinin reduces postoperative bleeding and the need for blood products in thoracic surgery: results of a randomized double-blind study
Eur. J. Cardiothorac. Surg.,
December 1, 2001;
20(6):
1122 - 1127.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|